Dr. Valentina Schneeberger is shown with her committee following her successfully dissertation defense on May 2, 2014. Her committee as pictured (from left) Keiran Smalley, Valentina, major professor Jerry Wu, Srikumar Chellappan, invited chair Z. Joe Zhou from the University of Oklahoma Health Sciences Center and Amer Beg. Dr. Schneeberger has accepted a postdoc position with Dr. Charles Rudin, Memorial Sloan Kettering Cancer Center.
Dr. Schneeberger's Publication Record while in the Program:
Schneeberger VE, Ren Y, Luetteke N, Huang Q, Chen L, Lawrence HR, Lawrence NJ, Haura EB, Koomen JM, Coppola D, Wu J. Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma.
Oncotarget. 2015 Mar 20;6(8):6191-202.
Schneeberger VE, Luetteke N, Ren Y, Berns H, Chen L, Foroutan P, Martinez GV, Haura EB, Chen J, Coppola D, Wu J. SHP2E76K mutant promotes lung tumorigenesis in transgenic mice.Carcinogenesis.2014 Feb 19.PMID:24480804
Win-Piazza H, Schneeberger V, Chen L, Pernazza D, Lawrence HR, Sebti SM, Lawrence NJ, Wu J. Enhanced anti-melanoma efficacy of interferon alfa-2b via inhibition of Shp2. Cancer Lett. 2012 Jan 31.